Leukemic and lymphomatous meningitis : incidence, prognosis and treatmentCHAMBERLAIN, Marc C; NOLAN, Craig; ABREY, Lauren E et al.Journal of neuro-oncology. 2005, Vol 75, Num 1, pp 71-83, issn 0167-594X, 13 p.Article

Central nervous system-directed preventative therapy in adults with lymphomaMCMILLAN, Andrew.British journal of haematology. 2005, Vol 131, Num 1, pp 13-21, issn 0007-1048, 9 p.Article

Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphomaALVAREZ, R; DUPUIS, J; BELHADJ, K et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1274-1279, issn 0923-7534, 6 p.Article

Intrathecal chemotherapy in lymphomatous meningitisCANOVA, Fabio; MARINO, Dario; TRENTIN, Chiara et al.Critical reviews in oncology/hematology. 2011, Vol 79, Num 2, pp 127-134, issn 1040-8428, 8 p.Article

DepoCyte^®, une formulation originale de cytarabine pour injection intrathécale dans le traitement des méningites lymphomateuses = DepoCyte^®, an original formulation of cytarabin for intrathecal injection in malignant lymphomatous meningitisCHATELUT, E.La Lettre du pharmacologue (Boulogne). 2009, Vol 23, Num 3, pp 109-111, issn 0984-452X, 3 p.Article